Alamar Biosciences
Latest round
- Series C
Last raised
- Feb 2024
Total raised
- $222M
Investors
- 6
About Alamar Biosciences
Founded in 2018 and based in California, US, Alamar Biosciences, Inc. operates as a biotechnology company for developing treatments for cancers. The company was co-founded by CEO Dr. Yuling Luo, COO Dr. Steve Chen, and Vice President of Technology Dr. Yiyuan Yin. In January 2026, Alamar Biosciences, Inc., Illumina Ventures and Sands Capital. Alamar Biosciences is a precision proteomics company that brings both sensitivity and parallel scale to proteomic analysis, which is systematic identification and quantification of the complete complement of proteins (the proteome) of a biological system such as cells, tissues, organs, biological fluids, or organisms. The company's two proprietary technology platforms, NULISA™ and Attobody™, work seamlessly with advances in genomics to achieve single-digit attomolar detection sensitivity, surpassing sensitive protein detection technology.
Who invested in Alamar Biosciences
6 investors across 3 rounds
See all investors in Alamar Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Alamar Biosciences
Who invested in Alamar Biosciences?
Alamar Biosciences has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alamar Biosciences raised?
Alamar Biosciences has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Alamar Biosciences last raise money?
Alamar Biosciences's most recent round on record is a Series C, in Feb 2024.
What does Alamar Biosciences do?
Founded in 2018 and based in California, US, Alamar Biosciences, Inc.
Where is Alamar Biosciences headquartered?
Alamar Biosciences is headquartered in Fremont, US.
Which VCs invest in companies like Alamar Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Alamar Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Alamar Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.